Location History:
- Hamburg, DE (2010)
- Saarland, DE (2013)
Company Filing History:
Years Active: 2010-2013
Title: Christoph Sarrazin: Innovator in Hepatitis C Research
Introduction
Christoph Sarrazin is a notable inventor based in Saarland, Germany. He has made significant contributions to the field of virology, particularly in the study of Hepatitis C virus (HCV) variants. With a total of 2 patents, his work has implications for the treatment and understanding of this viral infection.
Latest Patents
Sarrazin's latest patents focus on HCV variants that exhibit resistance to protease inhibitors, such as VX-950. These inventions provide methods and compositions related to the HCV variants. Additionally, they include innovative approaches for isolating, identifying, and characterizing multiple viral variants from patients. This research is crucial for developing effective treatments for individuals affected by Hepatitis C.
Career Highlights
Christoph Sarrazin is currently associated with Vertex Pharmaceuticals, Inc., a leading biotechnology company. His work at Vertex has allowed him to collaborate with other experts in the field, enhancing the impact of his research on Hepatitis C.
Collaborations
Some of his notable coworkers include Chao Lin and Tara Lynn Kieffer. Their collaborative efforts contribute to advancing the understanding of HCV and improving therapeutic strategies.
Conclusion
Christoph Sarrazin's innovative work in the field of Hepatitis C research highlights his role as a key inventor in virology. His patents and collaborations continue to pave the way for advancements in the treatment of this challenging viral infection.